DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization.
ACS Chem Biol
; 10(7): 1631-6, 2015 Jul 17.
Article
in En
| MEDLINE
| ID: mdl-25906160
ABSTRACT
The flavo-enzyme DprE1 catalyzes a key epimerization step in the decaprenyl-phosphoryl d-arabinose (DPA) pathway, which is essential for mycobacterial cell wall biogenesis and targeted by several new tuberculosis drug candidates. Here, using differential radiolabeling with DPA precursors and high-resolution fluorescence microscopy, we disclose the unexpected extracytoplasmic localization of DprE1 and periplasmic synthesis of DPA. Collectively, this explains the vulnerability of DprE1 and the remarkable potency of the best inhibitors.
Full text:
1
Collection:
01-internacional
Health context:
2_ODS3
/
3_ND
Database:
MEDLINE
Main subject:
Bacterial Proteins
/
Tuberculosis
/
Cell Wall
/
Alcohol Oxidoreductases
/
Mycobacterium tuberculosis
/
Antitubercular Agents
Limits:
Humans
Language:
En
Journal:
ACS Chem Biol
Year:
2015
Document type:
Article